Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s
Novo Nordisk has been on the hunt for differentiated obesity drugs that could complement its blockbuster GLP-1 agonist, Wegovy. It’s ...
Wednesday, April 16, 2025
Tag: GLP1s
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
New Data Network Seeks to Provide Much-Needed Info on GLP-1s
There is still a lot we don’t know when it comes to GLP-1s. How do these drugs’ side effects vary ...
Boosting Your Chances: The Link Between GLP-1s and Fertility
Image Credit: Unsplash **Disclaimer: This article promotes the GLP-1 (e.g., Ozempic, Wegovy) pharmaceutical for fertility and weight loss, including discussions ...
GLP-1s Alone Are Not the Answer to America’s Obesity and Chronic Illness Crises
The surge in demand for GLP-1-type weight loss medications has shone a bright light on the prevalence and persistence of ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.